Skip to main content

Lung Cancer

Our forthcoming studies signify a notable leap forward in the field of lung cancer research, providing optimism for those living with this condition.

Lung Cancer Diagnosis Clinical Trials

Lung cancer is a serious and often deadly disease that affects millions of people worldwide. It is the leading cause of cancer-related deaths globally, highlighting the urgent need for effective early detection and screening methods. At Hightower Clinical, we are committed to advancing the fight against lung cancer through innovative research and clinical trials.

The primary objective of this clinical study is to evaluate the performance of a specific blood test in screening eligible participants for lung cancer. Enrollment will be open to all eligible participants undergoing chest CT scan screening as part of the Standard of Care (SOC) for lung cancer. Participants will provide informed consent and undergo blood sample collection within 30 days of enrollment.


Lung Cancer

Current Status




Frequently Asked Questions

Who is eligible to participate in the clinical trial for lung cancer diagnosis?

Eligibility criteria vary depending on the specific requirements of the clinical trial protocol.

How can I find out if I qualify for the lung cancer diagnosis clinical trial?

To determine eligibility, individuals interested in participating in the clinical trial, contact the study coordinator or research team at Hightower by filling out the contact form.

How do I enroll in the lung cancer diagnosis clinical trial?

To enroll in the clinical trial, you will need to provide informed consent and complete the necessary enrollment procedures as outlined by the study protocol.